| Identification | |
| Name: | Bosutinib Methanoate |
| Synonyms: | 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile Methanoate;Bosutinib Methanoate;SKI 606 Methanoate |
| CAS: | 918639-10-8 |
| Molecular Formula: | C27H33Cl2N5O4 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C26H29Cl2N5O3.CH4O/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27;1-2/h11-14,16H,4-10H2,1-3H3,(H,30,31);2H,1H3 |
| Molecular Structure: | ![(C27H33Cl2N5O4) 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinec...](https://img.guidechem.com/pic/image/918639-10-8.png) |
| Properties | |
| Usage: | A novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. |
| Safety Data | |
 |
|
